Examining the Efficacy of a Newly Developed Smoking Cessation Program

NCT06746025 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2024-12-24

No results posted yet for this study

Summary

The goal of this clinical trial is to determine the success rate (efficacy) of a newly developed program to help smokers and vapers quit smoking. There will be no drugs of any nature involved, nor will there be any replacement addictions offered (ie; patches, gummies, etc.) It will also learn about the demographic profile of inbound participants. The main questions it aims to answer are:

Does the new program offer an improved success rate for smoking cessation? Does the program eliminate the need for long term "trigger" management? Does the program effectively diminish the anxiety that is normally associated with smoking cessation?

Participants will:

Attend a 1 hour group zoom session each week for the duration of the program (8 weeks).

Fill out an onboarding demographic questionnaire and exit demographic questionnaire.

Agree to a 6 month follow up questionnaire regarding their continued success/failure.

There are no physical meeting requirements. Participants can be located anywhere within the US.

Conditions

  • Nicotine Addiction
  • Smoking Cessation

Interventions

BEHAVIORAL

Quit Center cessation program

Lifestyle modifications based on the Quit Center cessation program.

Sponsors & Collaborators

  • Quit Center LLC

    lead INDUSTRY

Principal Investigators

  • Richard Rubino · Quit Center LLC, Managing Member

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-28
Primary Completion
2024-12-15
Completion
2024-12-21

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06746025 on ClinicalTrials.gov